Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

V-A drug treatment guidelines for five diseases due Oct. 1.

Executive Summary

V-A DRUG TREATMENT GUIDELINES FOR FIVE DISEASES will be promulgated by Oct. 1, Veterans Administration Chief Consultant for Pharmacy Benefits Management John Ogden said at a Sept. 17 meeting of the Academy of Managed Care Pharmacy. The diseases -- hyperlipidemia, non-insulin dependent diabetes, hypertension, chronic obstructive pulmonary disease and HIV -- are among the 10 most costly for the V-A, Ogden told attendees of the information management meeting in Itasca, Ill. The guidelines were drafted by a medical advisory panel and are now being circulated for review and comment. At least six more drug treatment guidelines are expected by the first of the year.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028911

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel